ETF Holdings Breakdown of IDXX

Stock NameIDEXX Laboratories Inc
TickerIDXX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45168D1046
LEIOGMTXK0LUU1HKV2P0J84

IDXX institutional holdings

The following institutional investment holdings of IDXX have been identified

Date ETF ISIN/Name Num Shares Book value
Total =0 USD 0
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with IDXX

IDEXX Laboratories (NASDAQ:IDXX) Rating Increased to Strong-Buy at Wall Street Zen
Wall Street Zen upgraded shares of IDEXX Laboratories (NASDAQ:IDXX – Free Report) from a buy rating to a strong-buy rating in a report released on Saturday. A number of other equities research analysts have also commented on IDXX. JPMorgan Chase & Co. upped their price target on IDEXX Laboratories from $550.00 to $675.00 and gave […] - 2025-09-21 05:43:05
QGRO, NYT, IDXX, JLL: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the American Century U.S. Quality Growth ETF (Symbol: QGRO) where we have detected an approximate $121.2 million dollar outflow -- that's a 5.8% decreas - 2025-09-09 11:48:20
Notable ETF Outflow Detected - GSLC, VRSN, IDXX, FAST
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF (Symbol: GSLC) where we have detected an approximate $164.7 million dollar outflow -- that's a 1. - 2025-08-27 12:02:04
GSLC, GOOG, IDXX, FAST: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF (Symbol: GSLC) where we have detected an approximate $428.9 million dollar outflow -- that's a 2. - 2025-08-19 11:47:53
IDEXX Laboratories (NASDAQ:IDXX) Reaches New 52-Week High After Better-Than-Expected Earnings
IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Free Report) reached a new 52-week high on Tuesday following a stronger than expected earnings report. The stock traded as high as $688.12 and last traded at $682.78, with a volume of 3331515 shares changing hands. The stock had previously closed at $535.54. The company reported $3.63 earnings per […] - 2025-08-06 02:50:49
IDEXX Laboratories (NASDAQ:IDXX) Shares Gap Up After Strong Earnings
IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Free Report)’s share price gapped up prior to trading on Monday following a better than expected earnings announcement. The stock had previously closed at $535.54, but opened at $662.24. IDEXX Laboratories shares last traded at $660.61, with a volume of 406,890 shares changing hands. The company reported $3.63 earnings […] - 2025-08-06 02:13:10
Private Advisor Group LLC Buys 295 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Private Advisor Group LLC increased its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 16.5% in the first quarter, Holdings Channel reports. The institutional investor owned 2,088 shares of the company’s stock after acquiring an additional 295 shares during the period. Private Advisor Group LLC’s holdings in IDEXX Laboratories were worth $877,000 at […] - 2025-07-29 04:30:54
IFP Advisors Inc Cuts Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
IFP Advisors Inc decreased its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 4.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 866 shares of the company’s stock after selling 37 shares during the period. IFP Advisors […] - 2025-07-27 09:10:45
HighPoint Advisor Group LLC Purchases 360 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
HighPoint Advisor Group LLC boosted its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 64.9% during the first quarter, Holdings Channel.com reports. The fund owned 915 shares of the company’s stock after acquiring an additional 360 shares during the period. HighPoint Advisor Group LLC’s holdings in IDEXX Laboratories were worth $400,000 at the […] - 2025-07-24 06:28:59
Crestwood Advisors Group LLC Acquires New Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Crestwood Advisors Group LLC purchased a new position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 829 shares of the company’s stock, valued at approximately $348,000. Several other hedge funds and other institutional […] - 2025-07-24 05:46:53
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Csenge Advisory Group
Csenge Advisory Group trimmed its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 18.1% during the first quarter, Holdings Channel.com reports. The firm owned 774 shares of the company’s stock after selling 171 shares during the period. Csenge Advisory Group’s holdings in IDEXX Laboratories were worth $318,000 as of its most recent SEC […] - 2025-07-23 06:34:52
Cerity Partners LLC Increases Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Cerity Partners LLC raised its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 63.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,630 shares of the company’s stock after buying an additional 7,235 shares during the period. […] - 2025-07-16 05:38:06
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives $558.11 Consensus Target Price from Analysts
IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten brokerages that are currently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation to the […] - 2025-07-15 03:48:50
IHI, IDXX, BDX, EW: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares U.S. Medical Devices ETF (Symbol: IHI) where we have detected an approximate $100.6 million dollar outflow -- that's a 2.2% decrease week ov - 2025-07-14 11:51:23
Concurrent Investment Advisors LLC Boosts Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Concurrent Investment Advisors LLC raised its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 59.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,370 shares of the company’s stock after buying an additional 509 shares during the quarter. Concurrent Investment […] - 2025-07-11 05:50:59
D.A. Davidson & CO. Purchases 126 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
D.A. Davidson & CO. boosted its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 7.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,800 shares of the company’s stock after purchasing an additional 126 shares […] - 2025-07-10 05:31:05
Jefferies Financial Group Initiates Coverage on IDEXX Laboratories (NASDAQ:IDXX)
Investment analysts at Jefferies Financial Group assumed coverage on shares of IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) in a research report issued to clients and investors on Tuesday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $625.00 price target on the stock. Jefferies Financial Group’s price target points to a potential […] - 2025-07-03 04:18:57
Golden State Wealth Management LLC Has $49,000 Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Golden State Wealth Management LLC increased its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 3,766.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 116 shares of the company’s stock after buying an additional 113 shares […] - 2025-07-02 05:26:56
Sequoia Financial Advisors LLC Acquires 252 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Sequoia Financial Advisors LLC boosted its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 15.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,937 shares of the company’s stock after buying an additional 252 shares […] - 2025-07-01 05:55:05
Spire Wealth Management Sells 144 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Spire Wealth Management lessened its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 31.2% during the first quarter, Holdings Channel reports. The fund owned 318 shares of the company’s stock after selling 144 shares during the period. Spire Wealth Management’s holdings in IDEXX Laboratories were worth $133,000 at the end of the most […] - 2025-07-01 05:07:01
Diversified Trust Co Invests $633,000 in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Diversified Trust Co purchased a new stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 1,508 shares of the company’s stock, valued at approximately $633,000. Several other hedge funds and other institutional investors have also made […] - 2025-06-30 06:30:45
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Kentucky Retirement Systems
Kentucky Retirement Systems reduced its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 1.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,549 shares of the company’s stock after selling 107 shares during the period. Kentucky Retirement Systems’ holdings in […] - 2025-06-24 05:53:00
Kentucky Retirement Systems Insurance Trust Fund Takes Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Kentucky Retirement Systems Insurance Trust Fund acquired a new position in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) during the 1st quarter, Holdings Channel reports. The firm acquired 2,363 shares of the company’s stock, valued at approximately $992,000. Other institutional investors have also recently made changes to their positions in the company. Hurley Capital LLC […] - 2025-06-24 05:17:11
World Equity Group Inc. Invests $247,000 in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
World Equity Group Inc. bought a new position in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) in the 1st quarter, HoldingsChannel reports. The fund bought 587 shares of the company’s stock, valued at approximately $247,000. Other hedge funds and other institutional investors have also modified their holdings of the company. Hurley Capital LLC acquired a […] - 2025-06-23 05:36:56
Analysts Set IDEXX Laboratories, Inc. (NASDAQ:IDXX) PT at $546.00
Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the nine brokerages that are covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation […] - 2025-06-20 02:52:51
Janney Montgomery Scott LLC Acquires 3,728 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Janney Montgomery Scott LLC lifted its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 9.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,786 shares of the company’s stock after purchasing an additional 3,728 shares during the period. […] - 2025-06-19 05:52:53
Miracle Mile Advisors LLC Has $231,000 Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Miracle Mile Advisors LLC grew its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 12.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 550 shares of the company’s stock after purchasing an additional 63 shares during the period. […] - 2025-06-12 05:18:47
IDEXX Laboratories (NASDAQ:IDXX) Cut to “Hold” at Wall Street Zen
Wall Street Zen lowered shares of IDEXX Laboratories (NASDAQ:IDXX – Free Report) from a buy rating to a hold rating in a report released on Friday morning. IDXX has been the subject of a number of other reports. Piper Sandler raised their target price on IDEXX Laboratories from $435.00 to $510.00 and gave the company […] - 2025-06-02 03:02:50
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Recommendation of “Moderate Buy” by Analysts
Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine ratings firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a […] - 2025-05-23 02:32:58
Rep. April McClain Delaney Buys IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares
Representative April McClain Delaney (D-Maryland) recently bought shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX). In a filing disclosed on May 02nd, the Representative disclosed that they had bought between $1,001 and $15,000 in IDEXX Laboratories stock on April 1st. Representative April McClain Delaney also recently made the following trade(s): Sold $1,001 – $15,000 in shares of […] - 2025-05-06 03:05:00

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.